Fluidigm Focusing on Partnerships as IPO Remains Goal

Speaking after the firm's presentation Monday at the UBS Global Life Sciences Conference, Fluidigm CFO Vikram Jog told GenomeWeb Daily News that the company still intends to go public, but the timing remains uncertain.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.